DEC 16 2002
. Attachment I
510(K) Summary
ProLite / Plasmalite MPX Pulsed Light System K 9 2 % 0 g (
This 510(K) Summary of safety and effectiveness for the ProLite / Plasmalite Pulsed Light System
is submitted in accordance with the requirements of the SMDA 1990 and following guidance concerning
the organization and content of a 510(K) summary.
Applicant: Medical Bio Care Nordic AB.
Address: Lona Knapes gata 5
421 32 Vastra Frolunda,
Sweden
Contact Person: Morgan Gustafsson
Telephone / Fax 46.31.709.30.70 — Phone
46.31.709.30.79 — Fax
Preparation Date: September 11, 2002
Device Trade Name: ProLite / Plasmalite MPX Pulsed Light System
Common Name: Pulsed Light for Photoepilation
Classification Name: Instrument, Surgical, Powered, laser
79-GEX, 21 CFR 878-48
Legally Marketed Predicate Device: EpiLight / Photoderm HR System
K number K991935
Description of the ProLite / Plasmalite The ProLite / PlasmaliteMPX Pulsed Light System delivers
MPX Pulsed Light System pulsed light at a wavelength beginning at a wavelength of
600 nm. The device consists of three interconnected
sections: The cabinet which houses the internal cooling
system, power supply and microcontroller, the umbilical to
the handpiece, and the handpiece, which houses the
waveguide
Intended use of the ProLite / Plasmalite The ProLite / Plasmalite MPX Pulsed Light System is
MPX Pulsed Light System indicated to permanently reduce unwanted hair.
Performance Data: Clinical studies were gonducted to provide assurance that
difference in the specifications of the ProLite / Plasmalite
MPX Pulsed Light System and the predicate device for hair
removal did not result in different performance during use.
These results were previously reported to the FDA in 510(K)
010927.
1-1

. Attachment I
: 510(K) Summary
ProLite / Plasmalite MPX Pulsed Light System :

Results of Clinical Study: Observation in the clinical study were recorded prior to
treatment and at 3-6 months after treatment. There was no
scarring in any subject.

The study demonstrated that selective photothermolysis
targeting melanin in the human hair follicle is an effective
tool for hair removal.

Conclusion: The ProLite / Plasmalite MPX Pulsed Light System is
substantially equivalent to other existing pulsed light
systems in commercial distribution for permanent hair
reduction in Dermatology and Plastic Surgery.

1-2

ae uo i oo So
§ € DEPARTMENT OF HEALTH & HUMAN SERVICES _ PublicHealthService
.) . : : . .
: DO : u, "7 Fead and Drug Adininistration
| . . . / 9200 Corporate Boulevard
ae a Rockville MD. 20850
. DEC 16 2002. |
: : - Medical Bio Care Sweden AB - . : OO
c/o Connie White Hoy / , oe
908 Stetson Street : :
- Woodland, California 95776 Lo
, Re: K023081 .
Trade/Device Name: Plasmalite Pulsed Light System for Permanent Reduction of Unwanted
Hair :
Regulation Number: 878.4810
Regulation Name: Instrument, surgical, powered laser
Regulatory Class: Class I
Product Code: GEX
Dated: September 12, 2002
Received: September 17, 2002
Dear Ms. Hoy: ,
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class LI (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR
Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in

a ~ Page 2—Ms. Connie WhiteHoy- oe
the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product .
: radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. .
- ‘This letter will allow you to begin marketing your device as described in your Section 510(k)
. premarket notification. The FDA finding of substantial equivalence of your device to a legally’
marketed predicate device results in a classification for your device and thus, permits your device | .
- to proceed to the market. . , :

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion
and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also,
please note the regulation entitled, "Misbranding by reference to premarket notification” (21CFR
Part 807.97). Other general information on your responsibilities under the Act may be obtained
from the Division of Smal! Manufacturers, International and Consumer Assistance at its toll-free
number (800) 638-2041 or (301) 443-6597 or at its Internet address
http://www. fda.gov/cdrh/dsma/dsmamain. html

Sincerely yours,

4 Cetin M. Witten, Ph.D., MD
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

a ' INDICATION FOR USE STATEMENT ve
510(k) Number: __ Pending KO22395\ a
Device Name: ProLite /Plasmalite MPX Pulsed Light System
Indications for Use:
The ProLite / Plasmalite MPX is intended to be used for the
permanent reduction of unwanted hair.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use / OR Over-the-Counter Use
(per 21 CFR 801.109)
(Division Sign-Off)
Division of General, Restorative
and Neurological Devices
22k) Number K 62308{

